Clinical Correlations of α2,6-Sialyltransferase Expression in Colorectal Cancer Patients
Hybridoma · 2000
DOI: 10.1089/027245700429828 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hybridoma, 2000. Verfasst von M Lise und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of Padova, Italy. Die Arbeit wurde bisher 64-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: NCI NIH HHS.
Themen: Onkologische Pflege
Abstract (Originalsprache)
We have previously demonstrated a link between alpha2,6-Sialyltransferase (alpha2,6-ST; E.C. 2.4.99.1) expression and differentiation of colon tumors. So far, information is not available relative to the expression of alpha2,6-ST in tumors and the survival of patients with colorectal cancer. We have examined the expression of alpha2,6-ST in a variety of colorectal adenocarcinomas (n = 46) at different stages of differentiation (G1 to G3) by immunoperoxidase assay using monoclonal antibody (MAb) 6B9. Clinical outcome of the patients in a 5-year follow-up study has been correlated with the expression of alpha2,6-ST in tumors surgically removed from the same patients. No significant difference in the alpha2,6-ST expression was noted when age, sex, and tumor locations (colon, rectum) were included as parameters. However, 52% of the moderate (G2) and well-differentiated (G1) adenocarcinomas showed stronger alpha2,6-ST expression compared with poorly differentiated (G3) adenocarcinomas. Notably, absence to moderate levels of tumor alpha2,6-ST expression was correlated with 100% survival in patients with stage I and II tumors compared with 64% survival in patients with strong tumor alpha2,6-ST expression (p < 0.01). These studies suggest a negative correlation between the expression of alpha2,6-ST in tumors and a good clinical outcome in colorectal cancer patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Surgery, University of Padova, Italy.
Förderung
- NCI NIH HHS
Zitieren
APA
Lise, M., Belluco, C., Perera, S. P., Patel, R., Thomas, P., & Ganguly, A. (2000). Clinical Correlations of α2,6-Sialyltransferase Expression in Colorectal Cancer Patients. Hybridoma. https://doi.org/10.1089/027245700429828
Vancouver
Lise M, Belluco C, Perera SP, Patel R, Thomas P, Ganguly A. Clinical Correlations of α2,6-Sialyltransferase Expression in Colorectal Cancer Patients. Hybridoma. 2000. doi:10.1089/027245700429828
BibTeX
@article{Lise2000,
author = {Lise, M and Belluco, C and Perera, S P and Patel, R and Thomas, P and Ganguly, A},
title = {Clinical Correlations of α2,6-Sialyltransferase Expression in Colorectal Cancer Patients},
journal = {Hybridoma},
year = {2000},
doi = {10.1089/027245700429828}
}
EUVIMED